Your browser doesn't support javascript.
loading
Phosphatase PP2A enhances MCL-1 protein half-life in multiple myeloma cells.
Slomp, Anne; Moesbergen, Laura M; Eldering, Eric; Kersten, Marie José; Minnema, Monique C; Peperzak, Victor.
Affiliation
  • Slomp A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Moesbergen LM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Eldering E; Department of Experimental Immunology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Kersten MJ; Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands.
  • Minnema MC; Cancer Center Amsterdam and LYMMCARE, Amsterdam, The Netherlands.
  • Peperzak V; Department of Hematology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
Cell Death Dis ; 12(3): 229, 2021 03 03.
Article in En | MEDLINE | ID: mdl-33658484
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protein Processing, Post-Translational / Lymphoma, Large B-Cell, Diffuse / Protein Phosphatase 2 / Myeloid Cell Leukemia Sequence 1 Protein / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Death Dis Year: 2021 Type: Article Affiliation country: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Protein Processing, Post-Translational / Lymphoma, Large B-Cell, Diffuse / Protein Phosphatase 2 / Myeloid Cell Leukemia Sequence 1 Protein / Multiple Myeloma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Cell Death Dis Year: 2021 Type: Article Affiliation country: Netherlands